|
Volumn 54, Issue 2, 2008, Pages
|
Do you approve of spending $300 million on HPV vaccination?: no.
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18;
UNCLASSIFIED DRUG;
WART VIRUS VACCINE;
ALPHAPAPILLOMAVIRUS;
CANADA;
ECONOMICS;
FEMALE;
HEALTH CARE COST;
HUMAN;
MASS SCREENING;
NOTE;
UTERINE CERVIX TUMOR;
VAGINA SMEAR;
VIROLOGY;
VIRUS INFECTION;
ALPHAPAPILLOMAVIRUS;
CANADA;
FEMALE;
HEALTH EXPENDITURES;
HUMANS;
MASS SCREENING;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
UTERINE CERVICAL NEOPLASMS;
VAGINAL SMEARS;
|
EID: 41149135504
PISSN: None
EISSN: 17155258
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (6)
|
References (0)
|